Locations:
SearchNational Center for Health Research (NCHR) at Ministry of Health and Prevention honors Cleveland Clinic Abu Dhabi as top research hospital in the UAE for the 2nd year in a row
images: 1
video: 0
audio: 0
text: 0
Content is property of Cleveland Clinic and for news media use only.
Cleveland Clinic Abu Dhabi
ABU DHABI, United Arab Emirates: the second consecutive year, Cleveland Clinic Abu Dhabi, part of the M42 group, has been recognized as the top health research hospital in the UAE by the National Center for Health Research at the Ministry of Health and Prevention (MoHAP). This prestigious recognition not only validates the hospital’s ground-breaking clinical innovations but also underscores its leadership in advancing medical research and education in the region.
As a provider of residency and fellowship programs, undergraduate health professional training, and Continuing Medical Education (CME), CCAD is the first hospital in the UAE to be accredited by both the Accreditation Council for Graduate Medical Education International (ACGMEI) and the Accreditation Council for Continuing Medical Education (ACCME). These efforts demonstrate its commitment to research excellence and education.
Dr. Sawsan Abdel-Razig, Chief Academic Officer at Cleveland Clinic Abu Dhabi, underscored the significance of this achievement, stating, "Being recognized as the top-rated research hospital in the UAE for the second consecutive year is a testament to the dedication and hard work of our entire team. At Cleveland Clinic Abu Dhabi, our multidisciplinary approach focuses on researching prevalent regional conditions to pioneer new treatments and elevate patient care standards. Research and education are at the core of our mission, enabling us to bring complex care closer to home.”
The NCHR plays a pivotal role at MOHAP in advancing MOHAP's health research strategies and promoting health research in the UAE. Since its inception, NCHR has been instrumental in recognizing research excellence in health and supporting healthcare facilities and academic institutions. Through the Institutional Research Excellence Awards, NCHR has actively worked to significantly enhance health and biomedical research performance and productivity in the UAE.
Dr. Abdel-Razig continued, "Our commitment extends beyond clinical excellence; we aim to advance medical knowledge and set new benchmarks in healthcare education. As we embark on another year, our unwavering dedication to research, education, and personalized care will continue to define our pursuit of delivering world-class healthcare in the UAE and beyond."
In 2023, Cleveland Clinic Abu Dhabi initiated 60 new research studies bringing the total number of 212 active studies, including ongoing projects from previous years.
The hospital also launched an enhanced Research Student Program, offering comprehensive education in research methodologies in 2023 and delivered the Fundamentals of Clinical Research course to trainees and faculty, for the third consecutive year.
Currently, the hospital is conducting three genome-based studies focused on liver health, breast health and obesity to further improve the health of the Emirati population. These studies utilize DNA to expedite the development of new treatments and personalized healthcare options.
Cleveland Clinic Abu Dhabi continues to lead in medical advancements, highlighted by its contributions to stroke care, adult cardiac surgery, antimicrobial stewardship, and extracorporeal life support. The hospital’s commitment to excellence has also earned it recognition as a Centre of Excellence (CoE) in multiple disciplines.
Cleveland Clinic Abu Dhabi, part of the M42 group, is a multispecialty hospital on Al Maryah Island in Abu Dhabi, UAE. Cleveland Clinic Abu Dhabi is a unique and unparalleled extension of US-based Cleveland Clinic’s model of care, specifically designed to address a range of complex and critical care requirements unique to the Abu Dhabi population. Cleveland Clinic Abu Dhabi has the following Institutes and Departments: Heart, Vascular & Thoracic, Neurology, Digestive Disease, Eye, Respiratory, Critical Care, Oncology, Transplant, Surgical Subspecialties, Medical Subspecialties, Emergency Medicine, Anesthesiology, Pathology & Laboratory Medicine, Imaging, Quality & Patient Safety, Clinical & Nursing, Research and Education Departments. In all, more than 50 medical and surgical specialties are offered at Cleveland Clinic Abu Dhabi.
The campus is also home to a stand-alone and dedicated cancer center, Fatima bint Mubarak Center. The state-of-the-art, facility provides patients with access to diagnostics and treatment options through world- class facilities across 24 clinical departments that include a range of cancer subspecialties and programs: Blood Cancers, Breast Cancers, Endocrine Cancers, Gastrointestinal Cancers, Genitourinary Cancers, Gynecological Cancers, Head and Neck Cancers, Neurological Cancers, Thoracic Cancers, Ophthalmological Cancers and Soft Tissue Cancers among others.
Cleveland Clinic Abu Dhabi provides patients in the region with direct access to the world’s best healthcare providers and Cleveland Clinic’s unique model of care that includes state-of-the-art amenities and world- class service standards closer to home. M42 is an Abu Dhabi-based, global tech-enabled healthcare company operating at the forefront of medical advancement.
Visit us atwww.clevelandclinicabudhabi.ae
